Cue Health Gets $28M Contract to Create Respiratory Multiplex Test for OTC and POC Use
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Respiratory Disease |
Cue’s new test would differentiate between influenza A/B, RSV, and COVID simultaneously, with results delivered in approximately 25 minutes.
Read MorePosted by Andy Lundin | Aug 3, 2023 | Company News, Hematology Instrumentation |
Roche will continue to offer Sysmex’ hematology products, complementing their total lab solutions portfolio, the companies say.
Read MorePosted by Andy Lundin | Aug 2, 2023 | Sepsis |
Cytovale announced the U.S. commercial launch of the IntelliSep sepsis test following FDA 510(k) clearance in December 2022.
Read MorePosted by Andy Lundin | Aug 1, 2023 | Dementias & Alzheimer’s |
Quest announced the availability a blood test for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease.
Read MorePosted by Andy Lundin | Jul 31, 2023 | Immunoassay Reagents & test Kits |
OnsiteGene has developed a sample-to-answer instrument that is designed to improve PCR testing, the PeakV.
Read More